TAMMY REED: Open Payments
NPI 1245871847 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$67 in 4 payments from 4 companies in 2025. Trend: 2023 $70 · 2024 $54 · 2025 $67
Food & beverage: $67
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Octapharma USA, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: VYVGART HYTRULO, EVKEEZA, OCTAGAM IMMUNE GLOBULIN (HUMAN), AREXVY.
Industry payments across MS — which companies pay providers there.
